Connor, Clark & Lunn Investment Management (CC&L)
VXRT

Connor, Clark & Lunn Investment Management (CC&L)’s Vaxart VXRT Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio VXRT Stock Details VXRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-1,889
Closed -$40K – 995
2016
Q3 		$40K Sell
1,889
-45
-2% -$712 ﹤0.01% 808
2016
Q2 		$30K Hold
1,934
– – ﹤0.01% 848
2016
Q1 		$32K Sell
1,934
-757
-28% -$13.5K ﹤0.01% 812
2015
Q4 		$57K Buy
2,691
+218
+9% +$4.79K ﹤0.01% 781
2015
Q3 		$54K Buy
2,473
+437
+21% +$10.6K ﹤0.01% 690
2015
Q2 		$46K Sell
2,036
-55
-3% -$1.35K ﹤0.01% 610
2015
Q1 		$53K Buy
+2,091
New +$57.6K ﹤0.01% 552
2014
Q2 		– Sell
-1,745
Closed -$129K – 642
2014
Q1 		$129K Buy
1,745
+409
+31% +$25.3K ﹤0.01% 647
2013
Q4 		$65K Buy
1,336
+118
+10% +$5.19K ﹤0.01% 710
2013
Q3 		$58K Buy
+1,218
New +$52.8K ﹤0.01% 501

Other funds holding VXRT

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $688M AUM 63.4% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s VXRT Position: Q4 2016 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Vaxart (VXRT) in Q4 2016, closing a stake of 1,889 shares — an estimated $40K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in VXRT in Q3 2013 and held it in 10 quarters. The position peaked at $129K in Q1 2014. 45 funds tracked by Wall St. Rank hold VXRT as of Q4 2016.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Vaxart position as of Q4 2016 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 1,889 Vaxart shares in Q4 2016, an estimated $40K.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Vaxart in Q3 2013 and held it in 10 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Vaxart position peaked at $129K in Q1 2014.
  • 45 funds tracked by Wall St. Rank held Vaxart as of Q4 2016.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q4 2016, filed 13 Feb 2017.